Boehringer Ingelheim claims rival’s heart drug for dogs infringes on its patents

Boehringer Ingelheim claims a rival will infringe on its patents for a canine congestive heart failure drug and filed a preemptive lawsuit to stop Dechra Veterinary Products from selling a generic version before patents expire.